Logo image
Cost-Effectiveness Analysis of Clinically Indicated Versus Routine Replacement of Peripheral Intravenous Catheters
Journal article   Open access   Peer reviewed

Cost-Effectiveness Analysis of Clinically Indicated Versus Routine Replacement of Peripheral Intravenous Catheters

Haitham W Tuffaha, Claire M Rickard, Joan Webster, Nicole Marsh, Louisa G Gordon, Marianne Wallis and Paul A Schuffham
Applied Health Economics and Health Policy, Vol.12(1), pp.51-58
2014
pdf
PDF - Author Accepted Version222.69 kBDownloadView
Accepted VersionPDF - Author Accepted Version Open Access
url
https://doi.org/10.1007/s40258-013-0077-2View
Published Version

Abstract

peripheral intravenous catheters cost-effectiveness analysis Queensland Health
Background: Millions of peripheral intravenous catheters are used worldwide. The current guidelines recommend routine catheter replacement every 72-96 h. This practice requires increasing healthcare resource use. The clinically indicated catheter replacement strategy is proposed as an alternative. Objectives To assess the cost effectiveness of clinically indicated versus routine replacement of peripheral intravenous catheters. Methods A cost-effectiveness analysis from the perspective of Queensland Health, Australia, was conducted alongside a randomized controlled trial. Adult patients with an intravenous catheter of expected use for longer than 4 days were randomly assigned to receive either clinically indicated replacement or third-day routine replacement. The primary outcome was phlebitis during catheterization or within 48 h after catheter removal. Resource use data were prospectively collected and valued (2010 prices). The incremental net monetary benefit was calculated with uncertainty characterized using bootstrap simulations. Additionally, value of information (VOI) and value of implementation analyses were performed. Results The clinically indicated replacement strategy was associated with a cost saving per patient of AU7.60(95 7.60 (95 % CI 4.96-10.62). The expected VOI was zero, whereas the expected value of perfect implementation of the clinically indicated replacement strategy was approximately AU$5 million over 5 years. Conclusion The clinically indicated catheter replacement strategy is cost saving compared with routine replacement. It is recommended that healthcare organizations consider changing to a policy whereby catheters are changed only if clinically indicated.

Details

Metrics

769 File views/ downloads
1585 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Economics
Health Care Sciences & Services
Health Policy & Services

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image